Osborne Clarke advises Fatro S.p.A. in its acquisition of a majority holding in Gunesli Aşı

Published on 6th August 2025

Fatro S.p.A., a leading Italian group in the veterinary pharmaceutical sector and one of the main players in Europe, has acquired a 51% stake in Gunesli Aşı, a Turkish company specialized in the production, import, and export of veterinary pharmaceutical products.

The transaction, approved by the relevant Turkish authorities, enables Fatro to take control of a strategic local entity, strengthening its direct presence in the Turkish market. Fatro had previously operated in the country through distribution channels; this acquisition marks a significant step in consolidating its position in a key region for the Eastern Mediterranean.

Proactiva Strategy M&A acted as financial advisor to the transaction. Legal assistance was provided by Osborne Clarke Italy, with a team composed of partners Federico Ferrara and Giuliano Lanzavecchia, and junior associate Matteo Tracanella, in collaboration with Istanbul-based law firm Pelister Keki Sarac & Co.

Connect with one of our experts